Pre IVF Evaluation of the Infertile Woman
Patients presenting for infertility have the advantage of receiving a complete preconception evaluation including recommended antenatal screening, appropriate referrals to specialists as necessary, and optimizing health for pregnancy. Testing to determine optimal treatment includes, at a minimum, ovarian reserve screening, uterine cavity evaluation, and semen analysis. Balancing psychological, emotional, and financial pressures with realistic expectations in a supportive physician–patient relationship is essential in guiding treatment. While not all infertile women require IVF to achieve pregnancy, the clinical algorithm remains the same as for those who ultimately proceed to IVF.
KeywordsCeliac Disease Spinal Muscular Atrophy Ovarian Reserve Infertile Woman Recurrent Pregnancy Loss
- 1.Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2009 Assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta, GA: US Department of Health and Human Services; 2011. http://www.cdc.gov/art/ART2009/PDF/ART_2009_Full.pdf. Accessed 2 Jan 2012.
- 4.NIH Consensus Statement on Celiac Disease. NIH Consens State Sci Statements. 2004; 21(1):1–22. http://consensus.nih.gov/2004/2004CeliacDisease118html.htm. Accessed 16 Mar 2012.
- 5.American Academy of Pediatrics Committee on Fetus and Newborn and the American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Antepartum care. Guidelines for perinatal care. 6th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2007.Google Scholar
- 7.Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online. 2011;23(4):421–39.http://web.ebscohost.com.ezp-prod1.hul.harvard.edu/ehost/pdfviewer/pdfviewer?sid=fa6e24c2-0db0-4fcc-9049-cec786f4bbc6%40sessionmgr4&vid=2&hid=13. Accessed 2 Jan 2012.PubMedCrossRefGoogle Scholar
- 12.Pratt LA, Brody DJ, Gu Q. Antidepressant use in persons aged 12 and over: United States, 2005–2008. NCHS data brief, no 76. Hyattsville, MD: National Center for Health Statistics. 2011. http://www.cdc.gov/nchs/data/databriefs/db76.htm. Accessed 1 Feb 2012.
- 15.Bayer SR, Alper MM, Penzias AS, editors. Boston IVF handbook of infertility. 3rd ed. New York: Informa Healthcare; 2011.Google Scholar
- 16.Fritz MA, Speroff L, editors. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2011.Google Scholar
- 18.van Rooij IA, Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril. 2003;79(3):482–8.PubMedCrossRefGoogle Scholar
- 34.Practice Committee of the American Society for Reproductive Medicine in collaboration with The Society of Reproductive Surgeons. Salpingectomy for hydrosalpinges before in vitro fertilization increases the success rate. Fertil Steril. 2008;90:S66–8.Google Scholar
- 38.Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab. 2005;90(1):581–7.PubMedCrossRefGoogle Scholar
- 41.The Practice Committee of the Society for Assisted Reproductive Technology and the Practice Committee of the American Society for Reproductive Medicine. Guidelines on the number of embryos transferred. Fertil Steril. 2008;90:S163–4.Google Scholar